Tong Ren Tang Technologies Co. Ltd.

SEHK:1666 Voorraadrapport

Marktkapitalisatie: HK$6.6b

Tong Ren Tang Technologies Inkomsten in het verleden

Verleden criteriumcontroles 2/6

Tong Ren Tang Technologies has been growing earnings at an average annual rate of 7.9%, while the Pharmaceuticals industry saw earnings growing at 5.7% annually. Revenues have been growing at an average rate of 10.7% per year. Tong Ren Tang Technologies's return on equity is 10.3%, and it has net margins of 9.5%.

Belangrijke informatie

7.9%

Groei van de winst

7.9%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie5.6%
Inkomstengroei10.7%
Rendement op eigen vermogen10.3%
Nettomarge9.5%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

We Think You Should Be Aware Of Some Concerning Factors In Tong Ren Tang Technologies' (HKG:1666) Earnings

Sep 06
We Think You Should Be Aware Of Some Concerning Factors In Tong Ren Tang Technologies' (HKG:1666) Earnings

Recent updates

There's Reason For Concern Over Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Massive 34% Price Jump

Oct 07
There's Reason For Concern Over Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Massive 34% Price Jump

Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?

Sep 28
Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?

We Think You Should Be Aware Of Some Concerning Factors In Tong Ren Tang Technologies' (HKG:1666) Earnings

Sep 06
We Think You Should Be Aware Of Some Concerning Factors In Tong Ren Tang Technologies' (HKG:1666) Earnings

Investor Optimism Abounds Tong Ren Tang Technologies Co. Ltd. (HKG:1666) But Growth Is Lacking

May 25
Investor Optimism Abounds Tong Ren Tang Technologies Co. Ltd. (HKG:1666) But Growth Is Lacking

Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly

Mar 28
Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly

Subdued Growth No Barrier To Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Price

Feb 01
Subdued Growth No Barrier To Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Price

With EPS Growth And More, Tong Ren Tang Technologies (HKG:1666) Makes An Interesting Case

Dec 20
With EPS Growth And More, Tong Ren Tang Technologies (HKG:1666) Makes An Interesting Case

Tong Ren Tang Technologies (HKG:1666) Could Easily Take On More Debt

Oct 12
Tong Ren Tang Technologies (HKG:1666) Could Easily Take On More Debt

Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 38% Discount?

Sep 19
Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 38% Discount?

Do Tong Ren Tang Technologies' (HKG:1666) Earnings Warrant Your Attention?

Apr 13
Do Tong Ren Tang Technologies' (HKG:1666) Earnings Warrant Your Attention?

Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?

Dec 01
Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?

Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly

Aug 30
Here's Why Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt Responsibly

Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 43% Discount?

Jul 11
Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 43% Discount?

Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly

Apr 21
Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly

We Think Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt With Ease

Dec 22
We Think Tong Ren Tang Technologies (HKG:1666) Can Manage Its Debt With Ease

Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly

Sep 06
Tong Ren Tang Technologies (HKG:1666) Seems To Use Debt Rather Sparingly

Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?

Apr 25
Is Tong Ren Tang Technologies (HKG:1666) Using Too Much Debt?

Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Intrinsic Value Is Potentially 22% Below Its Share Price

Mar 20
Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Intrinsic Value Is Potentially 22% Below Its Share Price

Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) A Great Dividend Stock?

Feb 21
Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) A Great Dividend Stock?

Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

Feb 03
Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

If You Had Bought Tong Ren Tang Technologies' (HKG:1666) Shares Three Years Ago You Would Be Down 61%

Jan 16
If You Had Bought Tong Ren Tang Technologies' (HKG:1666) Shares Three Years Ago You Would Be Down 61%

What Can We Learn About Tong Ren Tang Technologies' (HKG:1666) CEO Compensation?

Dec 28
What Can We Learn About Tong Ren Tang Technologies' (HKG:1666) CEO Compensation?

Does This Valuation Of Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Imply Investors Are Overpaying?

Dec 15
Does This Valuation Of Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Imply Investors Are Overpaying?

What Kind Of Shareholders Hold The Majority In Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Shares?

Dec 02
What Kind Of Shareholders Hold The Majority In Tong Ren Tang Technologies Co. Ltd.'s (HKG:1666) Shares?

Opbrengsten en kosten

Hoe Tong Ren Tang Technologies geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SEHK:1666 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 246,8776511,7100
31 Mar 246,8256201,7210
31 Dec 236,7735901,7320
30 Sep 236,8496111,6520
30 Jun 236,9246331,5720
31 Mar 236,4586081,4750
31 Dec 225,9925831,3780
30 Sep 225,8205461,3310
30 Jun 225,6495101,2840
31 Mar 225,5255091,2480
31 Dec 215,4005071,2120
30 Sep 215,2675091,2260
30 Jun 215,1335111,2400
31 Mar 214,8704891,1820
31 Dec 204,6074681,1250
30 Sep 204,4253871,0990
30 Jun 204,2423071,0730
31 Mar 204,3593621,0940
31 Dec 194,4764181,1160
30 Sep 194,6045231,0990
30 Jun 194,7316281,0820
31 Mar 194,8956531,1570
31 Dec 185,0606781,2310
30 Sep 185,0546811,2950
30 Jun 185,0476831,3590
31 Mar 185,0366751,3590
31 Dec 175,0256671,3590
30 Sep 174,8826241,3670
30 Jun 174,7395821,3750
31 Mar 174,7025891,3670
31 Dec 164,6655961,3590
30 Sep 164,5466031,2970
30 Jun 164,4266101,2350
31 Mar 164,2475751,1830
31 Dec 154,0675411,1310
30 Sep 153,9155291,0810
30 Jun 153,7645171,0320
31 Mar 153,5524909680
31 Dec 143,3414629040
30 Sep 143,2464468790
30 Jun 143,1514308550
31 Mar 143,0314108410
31 Dec 132,9113908260

Kwaliteitswinsten: 1666 has a high level of non-cash earnings.

Groeiende winstmarge: 1666's current net profit margins (9.5%) are higher than last year (9.1%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 1666's earnings have grown by 7.9% per year over the past 5 years.

Versnelling van de groei: 1666's earnings growth over the past year (2.9%) is below its 5-year average (7.9% per year).

Winst versus industrie: 1666 earnings growth over the past year (2.9%) did not outperform the Pharmaceuticals industry 6.4%.


Rendement op eigen vermogen

Hoge ROE: 1666's Return on Equity (10.3%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden